Conference Calendar

March 14-18 - American Association of Orthopaedic Medicine Annual Meeting 2017

March 14-December 31 - Canaccord Genuity Musculoskeletal Conference

Complete Calendar »

Earnings Calendar

No Upcoming Events Scheduled
Complete Calendar »

Read our research via:
email art

Weekly Email

rss art


app icon


app store icon


Orthopedic and Dental Industry News Complete Archive »


Stryker Enters Twenty-year Partnership with Indo UK Institute of Health's Medicity Program to Provide More Accessible Healthcare Solutions in India BY ANDREW VAHRADIAN, NOVEMBER 29, 2016

Stryker entered a twenty-year collaboration partnership agreement with Indo UK Institute of Health's Medicity Program (IUIH) to develop solutions to enhance the quality of healthcare in the country of India and to make such services more accessible and affordable for... more

Medtronic Launches its Orthopedic Solutions Initiative BY ANDREW VAHRADIAN, NOVEMBER 14, 2016

Medtronic launched its Medtronic Orthopedic Solutions initiative, a comprehensive offering that seeks to improve patient outcomes and reduce costs for hospitals/patients across an entire episode of care of total joint replacement procedures. The company has developed this new offering in... more

Amplitude Surgical Acquires the Remaining 40% Stake in Unimplant BY ANDREW VAHRADIAN, SEPTEMBER 28, 2016

Amplitude Surgical exercised the company's call option to acquire the remaining (40%) minority interests in its Brazilian subsidiary, Unimplant, for approximately €4.1 million ($4.6 million). Amplitude develops medical devices for lower-limb orthopedic procedures in the hip, knee and extremities segments,... more

Zimmer Biomet to Acquire Clinical Graphics BY ANDREW VAHRADIAN, SEPTEMBER 26, 2016

Zimmer Biomet entered into an agreement to acquire Clinical Graphics, B.V., a Dutch imaging company that specializes in 3-D range-of-motion simulation technology to help surgeons make treatment decisions for common hip conditions requiring early intervention. Clinical Graphics develops 3-D interactive... more

GE to Acquire Both Arcam AB and SLM Solutions for an Aggregate $1.4B BY ANDREW VAHRADIAN, SEPTEMBER 19, 2016

GE entered into agreements to acquire Arcam AB and SLM Solutions Group, two suppliers of additive manufacturing equipment, for approximately $1.4 billion in aggregate. Both transactions will be structured as a public tender offer for all of the outstanding shares... more

JRI Orthopaedics Completes Acquisition of Sheffield Medical Products BY ANDREW VAHRADIAN, AUGUST 5, 2016

JRI Orthopaedics completed its acquisition of Sheffield Medical Products (SMPL), a developer and supplier of medical disposables, instrumentation, and implants for joint replacement and revision surgery applications. SMPL's product portfolio is comprised of surgical instruments, trauma products and replacement implant... more

Wright Medical to Sell Legacy Tornier Large Joint Business to Corin Orthopaedics for $33M BY ANDREW VAHRADIAN, JULY 11, 2016

Wright Medical entered into an agreement to divest its hip and knee (large joint) businesses to Corin Orthopaedics for a purchase price of €29.7 million ($33 million), which values the portfolio at 0.9x 2016E revenues of $37 million and 6.0x... more

Amedica Prices $11M Public Offering BY ANDREW VAHRADIAN, JULY 5, 2016

Amedica priced a public offering of shares for gross proceeds of $11 million. Under the terms of the offering, the company will sell Class A Units at a public offering price of $1.00 per unit. Each Class A Unit consists... more

Zimmer Biomet Completes Acquisition of Compression Therapy Concepts BY ANDREW VAHRADIAN, JUNE 14, 2016

Zimmer Biomet completed the acquisition of Compression Therapy Concepts, Inc. (CTC), a New Jersey-based developer of medical devices and accessories for the prevention of deep vein thrombosis (DVT). CTC was founded in 1999 and aims to reduce the risk of... more

ISTO Technologies' Commercial Operations to be Acquired by Thompson Street Capital Partners BY ANDREW VAHRADIAN, JUNE 14, 2016

The private equity firm, Thompson Street Capital Partners (TSCP), entered into an agreement to acquire the commercial operations of ISTO Technologies (ISTO), a Missouri-based orthobiologics company that provides solutions for spine and orthopedic indications. Under the agreement, TSCP will acquire... more

Medtronic to Acquire Responsive Orthopedics BY ANDREW VAHRADIAN, JUNE 7, 2016

Medtronic announced the acquisition of Responsive Orthopedics, a developer of low-cost primary joint replacement systems. In order to address the various macroeconomic changes taking place in the U.S. health care system, Responsive Orthopedics has focused on developing a platform of... more

RoundTable Healthcare Partners to Acquire Symmetry Surgical for $129M BY ANDREW VAHRADIAN, MAY 9, 2016

RoundTable Healthcare Partners, a healthcare focused private equity firm, entered into an agreement to acquire Symmetry Surgical for an enterprise value of $129.5 million, valuing the business at 1.5x LTM revenues of $85.0 million, or 15.5x LTM EBITDA of $8.4... more

Stryker to Acquire Stanmore Implants for $52M BY ANDREW VAHRADIAN, MAY 1, 2016

Stryker entered into an agreement to acquire Stanmore Implants Worldwide Limited in an all cash transaction for £35.6 million ($51.9 million). Stanmore is an England-based developer of orthopedic implants and solutions for orthopedic adult and juvenile oncology, and complex primary... more

Smith & Nephew Launches its First 3D-printed Titanium Hip Implant System BY ANDREW VAHRADIAN, MARCH 2, 2016

Smith & Nephew launched its REDAPT Revision Acetabular Fully Porous Cup with CONCELOC Technology, the company's first 3D-printed titanium hip implant. REDAPT is indicated for revision cases where compromised bone makes implant fixation and stability more difficult to implement. Therefore... more

The Medical Center at Loma Linda University Reduces Orthopedic Procedure Costs by Instituting a Rep-less Sales Model BY ANDREW VAHRADIAN, JANUARY 28, 2016

As a broader effort to cut medical-device costs and improve clinical quality through greater standardization of devices used in surgical procedures, a small number of hospitals around the country are collaborating with manufacturers to train their own employees to provide... more

Smith & Nephew to Acquire BST-CarGel Product from Piramal Healthcare BY ANDREW VAHRADIAN, JANUARY 12, 2016

Smith & Nephew entered into an agreement to acquire all product and intellectual property assets of Piramal Healthcare (Canada) Limited's BST-CarGel product, a first-line cartilage repair product utilized in conjunction with microfracture and other bone marrow stimulation techniques for the... more

CMS Finalizes New Bundled Payment Initiative for Hip/Knee Replacements BY ANDREW VAHRADIAN, NOVEMBER 19, 2015

The Centers for Medicare & Medicaid Services (CMS) finalized its Comprehensive Care for Joint Replacement (CJR) payment model which will hold hospitals accountable for the quality of care they deliver to Medicare fee-for-service beneficiaries for hip and knee replacements and/or... more

Orchid Orthopedic Announces Acquisition of Alhenia AG BY ANDREW VAHRADIAN, SEPTEMBER 14, 2015

Orchid Orthopedic entered into a definitive agreement to acquire Alhenia AG, a Swiss-based provider of machined and coated orthopedic implants. Alhenia provides machined components, bio-compatible coatings and finishing services to device manufacturers in the hip, knee, spine and extremities markets... more

Researchers Utilize Nanotechnology to Develop an Antibiotic Delivery Approach to Protect Orthopedic and Dental Implants from Infection BY ANDREW VAHRADIAN, JULY 23, 2015

Researchers at the University of Sheffield demonstrated that the application of small quantities of antibiotics to the surface between the polymer layers of orthopedic and dental implants can help prevent bacteria and other harmful microorganisms from attaching, and subsequently growing... more

ConforMIS Proposes $173M IPO BY ANDREW VAHRADIAN, MAY 22, 2015

ConforMIS, Inc. filed an S-1 to raise up to $172.5 million through an initial public offering (IPO) of common shares. The price range and number of shares to be sold in the offering has not yet been determined. The company... more

Zimmer Receives Conditional Clearance from the European Commission to Acquire Biomet BY ANDREW VAHRADIAN, MARCH 30, 2015

The European Commission (EC) cleared Zimmer's proposed $13.4 billion cash/stock acquisition of Biomet, on the condition that the combined company sell three of its European businesses. Under the terms of the conditional clearance by the EC, Zimmer will need to... more

Researchers Develop Rheumatoid Arthritis Treatment that Eliminates the Need for Drugs BY ANDREW VAHRADIAN, JANUARY 9, 2015

Researchers at the at the Academic Medical Centre in Amsterdam are assessing a new treatment methodology for rheumatoid arthritis that can eliminate the need for patients to take drugs. The novel treatment involves a pacemaker-style bioelectronics device that is implanted... more

Corin Group to Acquire Optimized Ortho BY ANDREW VAHRADIAN, NOVEMBER 26, 2014

Corin Group entered into an agreement to acquire Optimized Ortho, an Australian orthopedics company that provides various technologies for improving orthopedic implant component positioning for total hip and knee arthroplasty. Optimized Ortho's key technology is its Optimized Positioning System (OPS),... more

Amedica Appoints New President & CEO BY ANDREW VAHRADIAN, OCTOBER 6, 2014

Amedica Corporation announced the appointment of Dr. Sonny Bal as the company's President and Chief Executive Officer. Dr. Bal has served as a member of Amedica's Board since February 2012, and as its Chairman since August 20th, 2014. He succeeds... more

Blackstone to Acquire Stake in Xinrong Best Medical Instrument for a Reported $100M BY ANDREW VAHRADIAN, SEPTEMBER 23, 2014

The Blackstone Group entered into an agreement to acquire an unspecified stake in Xinrong Best Medical Instrument Co., a Chinese-based developer of orthopedic implants with Trauma, Spine and Joint applications, for a reported $100 million. Xinrong is planning to target... more

Smith & Nephew Unveils New Discounted, Hospital-focused Sales Model BY ANDREW VAHRADIAN, AUGUST 14, 2014

Smith & Nephew unveiled a new hospital-focused sales model that will offer two of the company's primary hip and knee implants through multiyear contracts at an approximate discounted rate of one-third.
Pages-from-smith_nephew_q2_2014_results_presentation.png more

Johnson & Johnson Plans to Develop a Line of 3-D Printed Reconstructive Implants BY ANDREW VAHRADIAN, JUNE 26, 2014

Last month, Johnson & Johnson (JNJ) announced that the company plans to file for more than 30 major product approvals within its Medical Device & Diagnostic (MD&D) unit by the end of 2016, in order to bolster the segment's overall... more

Microport to Expand Wright Medical Presence BY JOHN MCCORMICK, JUNE 13, 2014

This week, MicroPort, China's largest and most successful private medtech company, announced that it will be investing $100 million over the next 5 years to add to Wright Medical's training capabilities. Having recently closed its acquisition of the Wright Medical... more

Study Links Rise in Total Knee and Hip Replacement Volumes to Obesity, Especially In Younger Adults BY ANDREW VAHRADIAN, JUNE 11, 2014

According to a recent study published in the Journal of Bone and Joint Surgery (JBJS), an increase in the prevalence of overweight and obesity levels in the U.S. accounted for 95% of the higher demand for knee replacements, with younger... more

Johnson & Johnson Plans to Launch 30 New Medical Devices by 2016 BY ANDREW VAHRADIAN, MAY 30, 2014

In the 2013 fiscal year, Johnson & Johnson's Pharmaceutical business grew 12% on a constant currency basis, outstripping the company's Medical Device & Diagnostic (MD&D) segment, which grew at 6%. Therefore, in order to bolster growth to its MD&D unit,... more

Zimmer to Acquire Biomet for $13.4B BY ANDREW VAHRADIAN, APRIL 24, 2014

Zimmer and Biomet announced that each of their respective Boards of Directors have approved a definitive agreement under which Zimmer will acquire Biomet in a cash and stock transaction valued at approximately $13.35 billion, including the assumption of net debt,... more

Study Demonstrates Joint Replacement Procedures are "Recession-proof" BY ANDREW VAHRADIAN, APRIL 11, 2014

A new study published in the Journal of Bone and Joint Surgery (JBJS), concluded that the economic recessions experienced in the 21st century up to this point, have not substantially hindered the growth trends for hip and knee arthroplasty in... more

Stryker to Acquire Berchtold Holding and Pivot Medical BY ANDREW VAHRADIAN, FEBRUARY 20, 2014

Stryker entered into definitive agreements to acquire Berchtold Holding, AG, a provider of surgical infrastructure equipment, for an enterprise value of $172 million, or 1.4x LTM revenues, and Pivot Medical, a developer of hip arthroscopy products that focus on treating... more


Amedica Corporation priced its initial public offering (IPO) of 3,500,000 shares of common stock at a public offering price of $5.75 per share, raising total proceeds of $20 million. This equates to an enterprise value of approximately $97 million, or... more

UK Moves to Ban Metal-on-Metal Hip Implants in NHS Hospitals BY ANDREW VAHRADIAN, NOVEMBER 20, 2013

Due to high failure rates and toxicity concerns, the United Kingdom has decided to ban metal-on-metal (MoM) hip implants in hip replacement surgeries performed at publicly funded National Health Service (NHS) hospitals. This announcement came after the National Institute for... more

The FDA Outlines Approach to Personalized Medicine BY ANDREW VAHRADIAN, OCTOBER 31, 2013

It is widely believed that personalized medicine will dramatically change the manner in which medical devices and drugs are developed, tested, and regulated. The FDA believes that with the progression of science, technology and the understanding of the underlying mechanisms... more

European Union Committee Votes in Favor of a Stricter Regulatory Process for Medical Devices BY ANDREW VAHRADIAN, OCTOBER 3, 2013

Members of the European Union parliament's Environment Committee (Committee), voted in favor of a new pre-market authorization (PMA) system that would employ randomized clinical trials for Class III, or high-risk, implantable devices under the oversight of the European Medicines Agency... more

Gender: An Important Parameter for Personalized Medicine BY ANDREW VAHRADIAN, AUGUST 26, 2013

The FDA’s Center for Devices and Radiological Health (CDRH) has launched its Health of Women Program, an initiative focused on improving women’s access to, and outcomes from, treatments incorporating medical devices. The initiaitive highlights that: 1) Women are less frequently... more

FDA to Conduct Study on Metal-on-Metal Hip Implant Corrosion BY ANDREW VAHRADIAN, AUGUST 13, 2013

In order to close a loophole in the Medical Device Amendments of 1976, the federal law under which medical devices were first regulated, the FDA issued a proposed order in January that required metal-on-metal (MoM) hip arthroplasty implant manufacturers to... more

Bioactive Glass Scaffolds Demonstrate Potential as Weight-bearing Implants BY ANDREW VAHRADIAN, AUGUST 1, 2013

Researchers at Missouri University of Science and Technology have developed a type of glass implant that could one day be used to repair injured bones in the arms, legs and other areas of the body that are most subject to... more

Smith & Nephew to Acquire Assets from Plato Grup BY ANDREW VAHRADIAN, JULY 11, 2013

Smith & Nephew announced an agreement to acquire certain assets related to the distribution of its orthopedic reconstruction, trauma and sports medicine products in Turkey, currently conducted through Plato Grup. The acquisition is being made through the local subsidiary of... more

Cholesterol-lowering Statins Could Lead to Musculoskeletal Injuries BY ANDREW VAHRADIAN, JUNE 25, 2013

A report published by JAMA Internal Medicine determined that while utilizing cholesterol-lowering statins can lower cardiovascular illnesses and death, it could also lead to musculoskeletal arthropathies and injuries associated with a wide variety of clinical presentations, including muscle weakness, muscle... more

Wright Medical to Divest OrthoRecon Business to MicroPort BY ANDREW VAHRADIAN, JUNE 20, 2013

Wright Medical announced it has entered a definitive agreement with MicroPort Medical, a subsidiary of MicroPort Scientific Corporation (HK: 0853), for the acquisition of Wright's OrthoRecon business at a cash purchase price of $290 million, valuing the unit at 1.1x... more

Musculoskeletal News Roundup 23-May-2013 BY LAUREN UZDIENSKI, MAY 23, 2013

MDT reports earnings ... OsteoGeneX receives SBIR grant ... FDA panel votes to reclassify pedicle screws for the thoracolumbosacral class II ... Depuy Synthes to discontinue ULTAMET Metal-on-Metal Articulation and COMPLETE Ceramic-on-Metal hip systems ... KFx receives new patents ... Benvenue Medical completes follow-up for KAST study ... Globus files suit against Depuy Synthes ... Blue Belt partners with DJO ... EOS announces Asia expansion ... Stryker and OrthoSensor extend co-marketing agreement for VERASENSE more

FDA to Tighten Regulation on Metal-on-Metal Hip Implants BY ANDREW VAHRADIAN, JANUARY 24, 2013

In order to close a loophole in the Medical Device Amendments of 1976, the federal law under which medical devices were first regulated, the FDA has issued a proposed order that will require metal-on-metal (MoM) hip arthroplasty implant manufacturers to... more

Musculoskeletal News Roundup 13-Sept-12 BY LAUREN UZDIENSKI, SEPTEMBER 12, 2012

FDA clears Iconacy Orthopedic Implants' I-Hip system ... Precision Spine's Slimplicity Solo Anterior Cervical Plate System 510(k)-cleared ... Amedica studies find "superior osseointegration and bacterial-resistant properties" of silicon nitride ... Ascendx Spine begins commercial shipments to Europe ... Osseon launches Osseoflex SN+ ... Smith & Nephew releases LEGION HK Hinge Knee ... NuVasive signs Premier agreement more

Musculoskeletal News Roundup 9-Aug-12 BY LAUREN UZDIENSKI, AUGUST 8, 2012

ATEC, TRNX announce earnings ... DePuy receives 510(k) for adolescent idiopathic scoliosis products ... ulrich medical launches golden gate Lateral Plate System ... WMGI subpoenaed over Profemur more

Musculoskeletal News Roundup 26-Jul-12 BY LAUREN UZDIENSKI, JULY 25, 2012

CNMD, Globus, IART, NUVA, OFIX, ZMH report 2Q:12 ... Histogenics raises $49M ... FH Orthopedics receives CE mark ... Discgenics receives stem cell patent ... Exactech, CONMED to collaborate on education program more

Musculoskeletal News Roundup 12-Jul-12 BY EDITOR, JULY 12, 2012

MAKO pre-announces ... Blue Belt's first surgery... CartiHeal raised $10M... Cleveland Clinic receives OREF grant... Stryker voluntary recall... more more

FDA to Review Metal-on-Metal Data This Week BY LAUREN UZDIENSKI, JUNE 27, 2012

Today the FDA's Orthopaedic and Rehabilitation Devices Panel will convene to review safety and efficacy data on metal-on-metal hips. The panel will look at data from published MoM literature as well as registry data from around the world. more

Musculoskeletal News Roundup 7-June-12 BY LAUREN UZDIENSKI, JUNE 7, 2012

J&J/Synthes deal may close next week ... Mindray to acquire controlling interest in Chinese orthopedic manufacturer ... FDA clear's Medicrea's LigaPASS ... K2M launches MESA Small Suture implant ... SNN voluntarily withdraws the optional metal liner component of its R3 Acetabular System ... ISTO receives U.S. patent ... SYK close to settling DOJ investigation into OtisKnee ... SANUWAVE comments on preclinical data more

Musculoskeletal News Roundup 24-May-12 BY LAUREN UZDIENSKI, MAY 24, 2012

Medtronic reports earnings ... AxioMed closes Series D round ... Mazor launches C-OnSite ... BlueCross BlueShield of Tennessee announces bundled payments for hip and knee replacements ... Baxano completes enrollment on iO-Flex study ... Benvenue announces Board appointments more

Clinical Roundup May 2012 BY LAUREN UZDIENSKI, MAY 10, 2012

Use of fibrin sealant QUIXIL in TKAs ... The accuracy of imaging in spine surgery ... ACL revision data from Denmark ... Ankle surgery and weight loss ... More surgeons working for hospitals more

Can Oral Bacteria Cause a Joint Replacement to Fail? BY LAUREN UZDIENSKI, APRIL 25, 2012

Researchers at Case Western Reserve University may have found a potential link between gum disease and joint health, with particular implications for failing joint replacements. Working collaboratively, dental, orthopedic and arthritis specialists tested the DNA in synovial fluid in 36 patients with both native and replacement joints. Some samples showed the presence of oral bacteria in the fluid, which the scientists suggest could be contributing to aseptic loosening or excessive wear in joint replacement patients when no infection is present. more

Clinical Roundup April 2012 BY LAUREN UZDIENSKI, APRIL 9, 2012

Cemented vs. uncemented hip hemiarthroplasty ... Returning to running after hip resurfacing surgery ... Adipose-derived stem cells in skeletal muscle-healing in a rat model ... Cortoss IDE results in vertebroplasty ... Patterns of disc degeneration ... Are local anesthetics associated with chondrotoxicity? more

Clinical Roundup February 2012 BY LAUREN UZDIENSKI, FEBRUARY 27, 2012

Defining conservative treatment in VCF cases ... Obesity and large joint outcomes ... Optimizing TKR rehab ... Navigation in TKR ... A review of PRP data ... Predicting recovery of walking ability in hip fracture patients more

Musculoskeletal News Roundup 16-Feb-12 BY LAUREN UZDIENSKI, FEBRUARY 16, 2012

co.don, CNMD, DJO and Synthes report ... Baxter closes Synovis acquisition ... Amedica announces $30M debt financing, launches Valeo VBR ... Cayenne Medical raises $10M ... SNN introduces POLARCUP Dual Mobility Hip ... Medtronic seeking royalties, interest relating to NUVA patent case ... Amedica appoints CEO more

Musculoskeletal News Roundup 9-Feb-12 BY LAUREN UZDIENSKI, FEBRUARY 9, 2012

Product launches from AAOS ... Nobel Biocare announces 4Q ... Hospitals settle Medicare fraud claims over kyphoplasty billing ... Updates on the American Joint Replacement Registry ... Stryker announces inventory management system rollout more

Musculoskeletal News Roundup 3-Nov-11 BY LAUREN UZDIENSKI, NOVEMBER 3, 2011

ATEC, ARTC, EXAC, IART, WMGI and more announce 3Q . . . FDA clears LDR's ROI-A Oblique ALIF cage . . . ATEC, Custom Spine, Globus, K2M, Medtronic and others debut new products at NASS . . . Relievant MedSystems starts enrolling SMART trial . . . Spine Wave starts EU NuCore study more

Musculoskeletal News Roundup 20-Oct-11 BY LAUREN UZDIENSKI, OCTOBER 20, 2011

KNSY, JNJ, Medicrea, SYK, SYST announce 3Q . . . BMTI receives Australian approval for Augment . . . FDA clears Medtronic's Aquamantys3 System . . . K2M launches RAVINE Lateral Access System . . . Medicrea highlights six products at Eurospine . . . Globus to fund MIS spine outcomes registry . . . Zimmer to distribute Benvenue's Kiva . . . Lanx creates Surgeon Advisory Board more

House Democrats Request Hearings on Metal-on-Metal BY LAUREN UZDIENSKI, OCTOBER 13, 2011

Democrats from the House Energy and Commerce Committee have asked Republican leaders to hold hearings on metal-on-metal hips and brain stents. In a letter, Democrats said these devices have caused "significant harm to human health". Bloomberg writes that the FDA has received more than 5,000 complaints about metal-on-metal hips, among about 500,000 patients who have received the devices; the backlash from the ASR alone is already expected to cost DePuy over $1 billion. more

Metal-on-Metal Hip Complaints Surging: NYT Analysis BY SANDER DUNCAN, AUGUST 23, 2011

The FDA received more complaints about metal-on-metal hip implants this year to date than in the preceding four years combined, according to a New York Times analysis of FDA data. more

Chicago Surgeons Give Back BY LAUREN UZDIENSKI, AUGUST 8, 2011

Founded in 1995, Operation Walk is a not-for-profit organization founded in 1995 with the aim of bringing needed large joint surgeries to patients throughout the globe, primarily in the third world. Volunteer surgical teams have participated in trips to Cuba, China, Nepal, Philippines, Nicaragua, Peru, Guatemala, El Salvador, Panama and Ecuador. Now the Chicago Tribune is praising two surgeons striving to help Chicago-area patients lacking insurance or access to hip or knee replacements. more

Musculoskeletal News Roundup 16-Jun-11 BY LAUREN UZDIENSKI, JUNE 16, 2011

Altor to acquire Orchid Orthopedic Solutions . . .Spinal Modulation closes $30M in funding . . . FDA approves DePuy's ceramic-on-metal hip . . . TSON announces 10,000th U.S. AxiaLIF implantation . . . Cayenne Medical partners with allograft supplier Parametrics more

Musculoskeletal News Roundup 28-Apr-11 BY LAUREN UZDIENSKI, APRIL 28, 2011

CNMD, IART, SYST, ZMH and more report earnings . . . FDA clears Biomet's Active Articulation E1 Dual Mobility Hip System . . . ORTHOCON receives EU, Canadian clearance to market HEMASORB . . . SI-BONE receives modification to its labeling . . . DJO Global introduces e-plus total knee replacement insert . . . Wright Medical launches FUSIONFLEX Demineralized Moldable Scaffold . . . Kuros regains certain technology rights from Baxter . . . Genzyme files two new HA infringement suits more

Musculoskeletal News Roundup 24-Feb-11 BY LAUREN UZDIENSKI, FEBRUARY 24, 2011

ATEC, MDT, NUVA report on 4Q spine market . . . IART, SMA report 4Q:10 . . . Mazor Robotics raises $6.3M . . . FDA clears Zimmer's TM-S Trabecular Metal Cervical Interbody Fusion Device . . . Smith & Nephew receives premium reimbursement in Japan for Oxinium hip . . . Intrinsic Therapeutics enrolls first patient in Barricaid study for anular closure . . . Zimmer reports clinical results for DeNovo NT Graft and the MotionLoc Screws more

Musculoskeletal News Roundup 17-Feb-11 BY LAUREN UZDIENSKI, FEBRUARY 17, 2011

ARTC, DJO, GENZ, OFIX and Synthes report earnings . . . Sonoma raises $22 million . . . Anika provides FDA update . . . AAOS product launches . . . Medtronic announces kyphoplasty data more

Zimmer Closes China Acquisition BY JOHN MCCORMICK, DECEMBER 21, 2010

This morning Zimmer announced that it has finalized its acquisition of China-based Beijing Montagne, a mainland company that develops large joint implants and instruments. more

Musculoskeletal News Roundup 16-Dec-10 BY LAUREN UZDIENSKI, DECEMBER 16, 2010

Theken Spine wins Ohio grant . . . Ellipse Technologies receives CE mark for the PRECICE limb lengthening device . . . Memometal Technologies launches MemoDerm Acellular Dermal Matrix and Smart Toe II Hammertoe Fixation System . . . Zimmer receives reimbursement premium from Japan for the Trabecular Metal Modular Cup . . . Stryker files patent infringement suit against Zimmer . . . Lanx appoints CEO more

JBJS Publishes 10-Year Data on Metal-on-Metal Hips BY LAUREN UZDIENSKI, NOVEMBER 29, 2010

Adding to the body of literature on hip resurfacing is a new level-four study published in JBJS. The paper emphasized that the best outcomes were associated with appropriate patient and implant selection, with the authors concluding from a case series that metal-on-metal resurfacing does offer long-term device survival in young, active patients. more

AAOS Launches Joint Registry Pilot Program BY LAUREN UZDIENSKI, OCTOBER 13, 2010

A national large joint registry championed by AAOS will be launched this month as a pilot program at 15 hospitals. The registry will track results based on details about patients, doctors, hospitals and implants with the aim of improving outcomes, and many large-joint manufacturers have voiced their support for the program. more

Musculoskeletal News Roundup 26-Aug-10 BY LAUREN UZDIENSKI, AUGUST 26, 2010

Corin, Medtronic, TiGenix report . . . DePuy warned over TruMatch Personalized Solutions System and Corail Hip System . . . FDA clears Medyssey's Zenius Thoracolumbar Spinal System . . . Binder Biomedical launches NEWTON Intervertebral Body Spacer System . . . CareFusion launches AVAmax Vertebral Balloon . . . DePuy recalls ASR system . . . Benvenue Medical enrolls first patient in VCF study . . . MAKO Surgical appoints Director more

With an Eye on Consulting Relationships, Sen. Grassley Probes Reporting Practices at Zimmer BY LAUREN UZDIENSKI, AUGUST 2, 2010

Zimmer received a letter from Sen. Chuck Grassley requesting data on the company's processes for tracking failure rates of its large joint systems, specifically when safety issues are raised by company consultants. more

Zimmer Expanding China Presence BY JOHN MCCORMICK, JULY 22, 2010

Zimmer's data rich earnings announcement this mornining contained an interesting nugget about their China plans. Zimmer announced that they have completed a definitive agreement to acquire Beijing Montagne Medical Device Co., Ltd. a 360-employee company that develops large joint implants... more

Tornier Files for IPO BY JOHN MCCORMICK, JUNE 8, 2010

Despite recent market turmoil, fast-growing extremities implant leader Tornier made a confident statement about its business outlook by filing for a $205 million initial public offering (IPO) yesterday. After a 16-month nuclear winter, healthcare IPOs came back with a vengeance... more

Musculoskeletal News Roundup 3-Jun-10 BY LAUREN UZDIENSKI, JUNE 3, 2010

Mazor announces first German GO-LIF sales . . . OrthoDynamix launches the ArthroSteer Biter . . . Osprey Biomedical introduces the Eagle Cervical Allograft Series . . . DOJ settles with Idaho orthopedists . . . Stryker and Wright Medical settle knee infringement suit . . . Amedica awarded patent . . . AOFAS releases position paper on total ankle replacement . . . Pioneer Surgical announces NuBac data . . . RepRegen reports StronBone data . . . Medtronic to report physician payments greater than $5,000, and Steve La Neve steps down from spine & biologics more

UK Identifies Higher-than-Anticipated Revision Rate for DePuy's ASR BY LAUREN UZDIENSKI, MAY 26, 2010

ASR.pngCiting registry data, the UK released a medical device alert noting that DePuy's ASR acetabular cups have a higher-than-expected revision rate. While regulators anticipated a revision rate of about 3%, the actual rate has been closer to 4-5%. In addition to the registry data, two of the UK clinical sites that implant the device have echoed the higher failure rate. DePuy has been marketing the device in the UK since 2003. more

Musculoskeletal News Roundup 13-May-2010 BY LAUREN UZDIENSKI, MAY 13, 2010

aap Implantate, ATEC, ANIK, BMTI, OSTE report Q1 earnings . . . SBi announces Olympus investment . . . Aesculap launches pedicle screw system . . . data on B Braun's Targon screw . . . BioSyntech files for bankruptcy more

Musculoskeletal News Roundup: AAOS Edition BY LAUREN UZDIENSKI, MARCH 11, 2010

OR_small.jpg The latest news from AAOS! VITA and MAKO report 4Q09 . . . ETEX receives 510(k) . . . DePuy, Integra, Medtronic, Smith & Nephew and more announce product launches . . . SEC Drops Wright Medical Investigation . . . BioMimetic Therapeutics shares study results . . . Long-term use of bisphosphonates may increase fracture risk . . . NeoStem wins research grant more

NYT Challenges Metal-on-Metal Hips BY LAUREN UZDIENSKI, MARCH 8, 2010

hip_small.jpg Wear debris and surgical technique are at the center of a New York Times article on metal-on-metal total hip components, with the paper suggesting that metal-on-metal correlates to poorer outcomes and higher revision rates. The article cites a metal-on-metal revision rate of 1-3%, with women affected more frequently than men. more

Musculoskeletal News Roundup 4-Mar-10 BY LAUREN UZDIENSKI, MARCH 4, 2010

knee.jpg Corin, Osteotech and Integra report 4Q . . . Baxter to acquire ApaTech for up to $330.0 million . . . Intrinsic Therapeutics closes on $18.0 million of a $20.0 million round . . . FDA schedules Orthopaedic and Rehabilitation Devices Panel meeting for Menaflex . . . Aetna and United Healthcare reverse prior policies and announce that they will cover NuVasive's XLIF . . . Congress delays Medicare pay cut more

Blue Cross and Blue Shield Names Spine, Large Joint Centers to its Blue Distinction Program BY LAUREN UZDIENSKI, FEBRUARY 16, 2010

Blue Cross and Blue Shield announced that they would broaden their "Blue Distinction" designation granted to high-performing hospitals to include spine and hip and knee centers. Blue Distinction hospitals have met objective, "evidence-based thresholds for clinical quality and safety" and... more

Musculoskeletal News Roundup 11-Feb-10 BY LAUREN UZDIENSKI, FEBRUARY 11, 2010

Earnings Nobel Biocare reported 4Q:09 revenues of EUR 156.0 million ($213.6 million), flat over the year-ago period and missing estimates by EUR 5.0 million ($6.9 million.) EPS of EUR 0.21 ($0.29) missed estimates by EUR 0.05 ($0.07). The company called... more

Musculoskeletal News Roundup 12-Nov-09 BY LAUREN UZDIENSKI, NOVEMBER 12, 2009

Earnings Alphatec Holdings, Inc. announced record consolidated revenue of $32.7 million in 3Q:09, which represents 27% growth over 3Q:08. U.S. revenue increased 21% over the prior-year third quarter and 28% over the first nine months of 2008. International revenue was... more

Wright Medical Receives FDA Approval for Conserve Plus Hip Resurfacing Device BY LAUREN UZDIENSKI, NOVEMBER 10, 2009

Wright Medical announced that their Conserve Plus hip resurfacing device received long-awaited FDA approval, which the company said was supported by clinical data on over 1,300 patients with up to eight years of follow-up. The company plans to initiate surgeon... more

Looming Tantalum Shortage May Impact Orthopedic Devices BY LAUREN UZDIENSKI, SEPTEMBER 29, 2009

A new report from Roskill Information Services predicts a worldwide shortage of tantalum, a porous metal used in coating orthopedic devices. Tantalum has been demonstrated to facilitate a bond between an implant and the surrounding bone, with additional benefits including... more

JBJS: Orthopedics in 2020 BY LAUREN UZDIENSKI, SEPTEMBER 10, 2009

An article in JBJS outlined the evolving need for musculoskeletal care in the coming decade, addressing changes in demographics, disease incidence, treatment modalities and delivery of orthopedic services. These factors illustrate some of the growth drivers in orthopedics and help... more

Hip Fractures on the Decline in Canada BY LAUREN UZDIENSKI, AUGUST 31, 2009

New data published in the Journal of the American Medical Association show a steady decline in hip fractures in Canada from 1985 through 2005. While the absolute number of fractures increased over that period based on the increasing elderly population,... more

FDA Panel Recommends DePuy's Ceramic-on-Metal Hip for Approval BY LAUREN UZDIENSKI, AUGUST 18, 2009

An FDA panel unanimously determined on Tuesday that DePuy's ceramic-on-metal hip, the Pinnacle CoMplete, is safe and effective, essentially recommending it for market approval. The panel also recommended modifying the labeling and undertaking a post-market study as conditions for approval.... more

Protein May Predict Severe Osteoarthritis BY LAUREN UZDIENSKI, AUGUST 18, 2009

Researchers have identified a protein marker that predicts the onset of severe OA, according to a study published in the journal Arthritis & Rheumatism. Seeking an OA predictor apart from age and weight, scientists focused on vascular cell adhesion molecule... more

Vertebral and Hip Fractures Associated with Increased Mortality Risk BY LAUREN UZDIENSKI, AUGUST 17, 2009

According to a study published in the Canadian Medical Association Journal, patients 50 and older who suffer vertebral and hip fractures may also have an increased risk of mortality. Results showed that 16% of people who develop a vertebral fracture... more

House Proposes Artificial Joint Registry BY LAUREN UZDIENSKI, JUNE 22, 2009

Representatives Bill Pascrell Jr. (D-NJ) and Lloyd Doggett (D-TX) introduced a bill in the House last week that would establish a U.S. joint registry. If the registry is established, the U.S. would follow Australia, England and Sweden in creating similar... more

For Athletes, Stronger Knees May Leave Hips Exposed BY LAUREN UZDIENSKI, JUNE 11, 2009

High-profile injuries in professional athletes can draw attention to training and treatment gaps in everyday sports medicine. For example, Tiger Woods' well-publicized ACL repair may have helped encourage athletes to build leg strength to protect the knees. However, a new... more

New Studies Question Efficacy of Hip Resurfacing BY LAUREN UZDIENSKI, JUNE 8, 2009

The promise of hip resurfacing seems to have faded somewhat with the publication of some new studies showing that outcomes for the procedure are similar to those associated with a traditional hip replacement. Additionally, the surgery has been found to... more

Musculoskeletal News Roundup 4-Jun-2009 BY LAUREN UZDIENSKI, JUNE 4, 2009

Funding Active Implants raised $10.0 million in a Series C preferred stock offering. The company is developing the TriboFit Hip and NUsurface implant systems based on its polycarbonate urethane technology. In conjunction with the financing round, the company appointed Charles... more

Musculoskeletal News Roundup 21-May-09 BY LAUREN UZDIENSKI, MAY 21, 2009

Earnings Medtronic reported FQ4:09 revenue of $3.8 billion, representing a 5% increase (constant currency) over FQ4:08 and in line with estimates. Adjusted EPS for the quarter was $0.82, also in line with estimates. Spine and biologics revenue was $881.0 million,... more

Early Earnings Reports Show Growth Despite Economy BY LAUREN UZDIENSKI, APRIL 16, 2009

DePuy and Biomet have kicked off 1Q earnings season on a positive note, offering a view of industry growth that may be outpacing expectations. These two companies, which together comprise more than a third of the ortho market, reported 7%... more

Teriparatide (Forteo) May Accelerate Bone Healing BY LAUREN UZDIENSKI, APRIL 15, 2009

Teriparatide, a recombinant form of parathyroid hormone marketed by Eli Lilly as Forteo, has been shown to stimulate stem cell production and accelerate the healing of fractured bones, according to study data presented at the Orthopaedic Research Society meeting in... more

FDA Requiring Safety and Effectiveness Data on Certain Class III Devices BY DAVID KRESSEL, APRIL 9, 2009

The FDA announced yesterday that it would be requiring companies who manufacture 25 specific devices marketed prior to 1976 to submit safety and effectiveness data so they can gauge product risk. The agency says this is in response to January's... more

Musculoskeletal News Roundup 9-Apr-09 BY LAUREN UZDIENSKI, APRIL 9, 2009

Earnings Biomet reported FQ3:09 revenues of $615 million, a 7% (constant currency) increase over FQ3:08. Among segments, recon reported growth of 7%, with hip up 10%, knee up 9%, fixation up 4% and dental down 10%, which the company attributed... more

Four of Big Five Settle with DOJ; Compliance Monitors Leave BY DAVID KRESSEL, MARCH 31, 2009

Eighteen months after the Department of Justice entered into Deferred Prosecution Agreements (DPA) with Smith & Nephew, Johnson & Johnson (Depuy), Zimmer and Biomet, and a Non-Prosecution Agreement with Stryker, the DOJ has announced it has dismissed the criminal charges... more

Musculoskeletal News Roundup 5-Mar-09 BY LAUREN UZDIENSKI, MARCH 5, 2009

Earnings Alphatec Spine reported consolidated revenues for 4Q:08 of $28.4 million, an increase of 33% from the $21.3 million reported for 4Q:07. U.S. revenues for 4Q:08 were $22.0 million, an increase of 29% from the $17.1 million reported for 4Q:07.... more

Musculoskeletal News Roundup 26-Feb-09 BY LAUREN UZDIENSKI, FEBRUARY 26, 2009

Earnings Artimplant reported 4Q:08 revenues of SEK 4.6 million ($0.6 million), down from SEK 5.0 million ($0.8 million) in 4Q:07. During the quarter, the company reported sales of 900 Artelon Spacers (down from 1,100 in 4Q:07) and 300 units of... more

Space Travel Is Rough on the Musculoskeletal System BY LAUREN UZDIENSKI, FEBRUARY 4, 2009

According to a new study, astronauts experience more bone deterioration during space travel than previously thought, putting them at risk for fracture and deformity of the hip and spine. Researchers at UC Irvine and UC San Francisco reviewed hipbone strength... more

Musculoskeletal News Roundup 29-Jan-09 BY LAUREN UZDIENSKI, JANUARY 29, 2009

Earnings Kensey Nash reported FQ2:09 revenues of $20.8 million, up 6% over the year-ago period and beating estimates by $0.4 million. Net income for the quarter was $5.2 million, or $0.44 per diluted share, beating estimates by $0.04 and representing... more

WHO Tool Helps Physicians Predict Fracture Risk BY LAUREN UZDIENSKI, DECEMBER 23, 2008

In an effort to individualize treatment for patients presenting with fractured bones as well as make treatment more cost-effective, the WHO has launched a web tool to help physicians assess the likelihood of future fractures. Knowing future fracture risk can... more

Musculoskeletal News Roundup 20-Nov-08 BY LAUREN UZDIENSKI, NOVEMBER 20, 2008

Earnings Medtronic reported FQ2:09 revenues of $3.57 billion, up 14% (8% constant currency) over the year-ago period and missing estimates by $0.12 billion. Non-GAAP net earnings and diluted earnings per share were $758.0 million, or $0.67 per diluted share, missing... more

Musculoskeletal News Roundup 13-Nov-08 BY LAUREN UZDIENSKI, NOVEMBER 13, 2008

Earnings aap Implantate AG reported sales for the first nine months of 2008 of EUR 24.2 million ($35.0 million), up 30% from the same period last year. The company attributed the sales growth to the Traumatology & Orthopaedics division, where... more

Squeaky-Hip Case Against Stryker Dismissed in Colorado BY LAUREN UZDIENSKI, NOVEMBER 10, 2008

A Colorado judge dismissed Jama Parker's lawsuit against Stryker over a squeaky ceramic-on-ceramic hip. The court determined that since the Trident system has PMA clearance, Parker's claims were preempted. Last February, an 8-1 Supreme Court decision upheld preemption in Reigel... more

Musculoskeletal News Roundup 9-Oct-08 BY LAUREN UZDIENSKI, OCTOBER 9, 2008

M&A Life Spine, Inc. has acquired the "majority" of the intellectual property of Spinal Generations, LLC. Neither details on the acquired technology nor terms of the transaction were disclosed. Funding Harvard received a $125 million donation from Synthes Chairman Hansjorg... more

Medical Tourism at Home: U.S. Hospitals Competing with Foreign Pricing BY LAUREN UZDIENSKI, SEPTEMBER 10, 2008

The Wall Street Journal this morning revealed a new variation on medical tourism: patients are traveling for medical procedures, though not overseas. Medical tourism arose from skyrocketing U.S. healthcare costs; a hip replacement can cost $43,000 domestically and a mere... more

U.K. Study Finds 1 in 75 Patients Undergo Large Joint Revision BY LAUREN UZDIENSKI, SEPTEMBER 8, 2008

Data from about 160,000 U.K. patients who received hip or knee replacements between 2003 and 2006 show an overall revision rate of one in 75, or 1.4%. Overall, this rate is low, but it was affected by the type of... more

Musculoskeletal News Roundup 14-Aug-08 BY LAUREN UZDIENSKI, AUGUST 14, 2008

Earnings BioMimetic Therapeutics reported a 2Q:08 net loss of $9.2 million, or $0.50 per diluted share, widening from a net loss of $6.4 million, or $0.35 per diluted share, in 2Q:07. Clinical highlights for the quarter include the announcement of... more

"Lessons Learned" from a Hip Resurfacing IDE BY LAUREN UZDIENSKI, AUGUST 13, 2008

Hip resurfacing devices have only become available in the U.S. in the last two years (Smith & Nephew introduced the BHR in 2006 and Stryker began distributing Corin's Cormet in 2007), and with the relatively recent launch comes an "incomplete"... more

NY Times Calls for National Joint Registry BY LAUREN UZDIENSKI, JULY 29, 2008

Following Zimmer's announcement that the company would suspend sales of the Durom acetabular cup, the New York Times suggested this morning that the concerns about Durom could've been identified sooner if the U.S. had a national joint registry in place.... more

Zimmer Suspends Durom Sales, Cuts Guidance BY LAUREN UZDIENSKI, JULY 23, 2008

Zimmer's announced yesterday that they would voluntarily suspend sales of the Durom Acetabular Component in the U.S. while they update the labeling and conduct further surgeon training on the product. As a result, the company is lowering full-year revenue guidance... more

Study Finds Hip and Knee Arthroplasty Worthwhile for the Elderly BY HAL BRIGHAM, JULY 21, 2008

A study published in the July 14, 2008 issue of Archives of Internal Medicine contends that hip and knee arthroplasty surgeries may be more beneficial to elderly patients than once believed. The study reports that surgery is not only more... more

New "Smarthroscope" Will Assess Extent of Tissue Damage BY LAUREN UZDIENSKI, JUNE 3, 2008

Queensland University Of Technology researchers are developing a device they call a "smarthroscope," designed to be a more sensitive alternative to an arthroscope. Professor Kunle Oloyede, who received a grant from the National Health and Medical Research Council to develop... more

Stryker's Resurfacing Sales Disappoint; Corin Shares Plummet BY LAUREN UZDIENSKI, MAY 20, 2008

Stryker announced last week that sales of Corin's Cormet hip resurfacing system, which Stryker distributes exclusively in the U.S., were not meeting expectations. The company will not order more Cormet systems until December. Shares of both Stryker and Corin fell... more

New York Times, FDA Perk Up Their Ears for Squeaky Hips BY LAUREN UZDIENSKI, MAY 13, 2008

Stryker's ceramic-on-ceramic hip, the Trident, came to market in 2003 with the promise of providing a more durable alternative for younger patients seeking a THA. A traditional metal/poly hip lasts about ten years, so ceramic seemed to be the answer... more

Musculoskeletal News Roundup 17-Apr-08 BY LAUREN UZDIENSKI, APRIL 17, 2008

Earnings Biomet reported FQ3:08 net sales of $603.1 million, a 14% increase over the year-ago period. Excluding the impact of foreign currency, net sales increased 10%. U.S. revenue was $351.6 million. Adjusted net income for the third quarter was $25.2... more

AAOS: New Research Shows Hip, Knee Replacements Skyrocketing, Plus the Efficacy of Gender Implants and Hip Resurfacing BY LAUREN UZDIENSKI, MARCH 12, 2008

Clinical research presented at AAOS's annual meeting included a number of large-joint studies, one of which showed that hip and knee replacement procedures will climb to 572,000 and 3.4 million, respectively, in 2030. That's 101% more hip replacements and 525%... more

Musculoskeletal News Roundup 6-Mar-08 BY LAUREN UZDIENSKI, MARCH 6, 2008

Earnings Anika Therapeutics reported 4Q:07 product revenue of $7.9 million, in line with estimates and up from $5.08 million for the same period last year. The revenue growth was attributed to domestic and international sales of the ORTHOVISC product line,... more

Musculoskeletal News Roundup 21-Feb-08 BY LAUREN UZDIENSKI, FEBRUARY 21, 2008

Earnings ArthroCare reported 4Q:07 revenues of $87.5 million, beating estimates by $1.7 million, representing a 25% increase over the year-ago period. Net income was $14.5 million, or $0.50 per diluted share, missing estimates by a penny and representing a 78%... more

Musculoskeletal News Roundup 7-Feb-08 BY LAUREN UZDIENSKI, FEBRUARY 7, 2008

Earnings Smith & Nephew announced 4Q:07 revenues of $967.0 million, beating estimates of $933.0 million and reflecting a 25% (reported) increase over 4Q:06. Adjusted earnings per share was $0.16, in line in estimates and up 10% over the year-ago period.... more

Musculoskeletal News Roundup 25-January-08 BY LAUREN UZDIENSKI, JANUARY 24, 2008

Earnings JNJ reported 4Q:07 revenues of $15.96 billion, up 17% over the year-ago period and beating consensus estimates of $15.4 billion. Net income was $2.37 billion, or $0.82 per share, missing estimates by $0.04. Depuy reported 4Q:07 sales of $1.21... more

Revision Total Hip Arthroplasty Benefits Patients 80+ BY LAUREN UZDIENSKI, JANUARY 7, 2008

Testing a common belief that revision total hip arthroplasty is associated with a high complication rate in the very elderly, researchers at Philadelphia's Rothman Institute for Orthopedics retrospectively evaluated outcomes in over 300 THA patents. There were two groups of... more

Medtronic Expands in China with Weigao Joint Venture BY LAUREN UZDIENSKI, DECEMBER 19, 2007

Medtronic announced plans yesterday to bring spine and orthopedic therapies to the Chinese market through a joint venture with Shandong Weigao Group Medical Polymer Company Limited. Under the joint venture agreement, the companies will sell spine and orthopedic products, including... more

Musculoskeletal News Roundup 13-Dec-07 BY LAUREN UZDIENSKI, DECEMBER 13, 2007

Earnings Tutogen reported FY07 revenues of $53.8 million, an increase of 42% over FY06. The Company reported net income of $6.8 million, or $0.36 per fully diluted share in fiscal year 2007 compared to a net loss of $0.6 million,... more

Musculoskeletal News Roundup 29-Nov-07 BY LAUREN UZDIENSKI, NOVEMBER 29, 2007

Regulatory Amedica received FDA clearance for their Valeo™ Pedicle Screw system, a low profile and modular pedicle screw system intended for non-cervical pedicle fixation from the T1 through L5. Corin announced FDA clearance for additional sizes of its Cormet hip... more

Musculoskeletal News Roundup 1-Nov-07 BY LAUREN UZDIENSKI, NOVEMBER 1, 2007

Earnings DJO reported 3Q:07 net revenues of $119.8 million, up 5.8% over 3Q:06. Excluding a 2006 revenue benefit from shipping terms and clearing of product backorders associated with Aircast, 3Q:07 revenue was up 7.6% to $121.8 million, in line with... more

Musculoskeletal News Roundup 20-Sept-07 BY LAUREN UZDIENSKI, SEPTEMBER 18, 2007

Earnings AOI Medical reported a 1H:07 loss of $1.8 million, increasing from a loss of $0.97 million in the comparable half. The company attributed the loss to increased expenses. They expect their product, the Balloon Assisted Management of Spine Fractures,... more

JBJS: U.K. NICE Guidelines Have "Little Impact" on Surgeons' Product Selection BY LAUREN UZDIENSKI, SEPTEMBER 10, 2007

The July U.K. edition of JBJS reported results of a study evaluating the impact of the U.K.'s National Institute for Health and Clinical Excellence (NICE) guidelines for hip replacements. NICE publishes guidelines to promote "good health and the prevention and... more

Nanowire Coating Shows Promise for Ortho, Dental Reconstruction BY LAUREN UZDIENSKI, AUGUST 29, 2007

Researchers at the University of Arkansas, Fayetteville developed a nanowire coating that could prove to be a simple, inexpensive method for increasing adhesion of tissue to hip, dental and other implants. The process of preparing the coating is simple: an... more

CMS Finalizes 2008 Reimbursement Increases BY LAUREN UZDIENSKI, AUGUST 2, 2007

CMS released its final rule for the FY2008 Inpatient Prospective Payment System (IPPS). As we noted when the draft rule was announced in April, ortho payments will mostly increase next year. The rule also confirms that CMS will implement new... more

Musculoskeletal News Roundup 26-July-07 BY LAUREN UZDIENSKI, JULY 26, 2007

Earnings Stryker reported revenues of $1.46 billion, beating estimates of $1.44 billion and increasing 16% from $1.26 billion in 2Q:06. 2Q:07 earnings were $269.1 million, or $0.65 per share, beating estimates of $0.61 and up from $0.52 in the comparable... more

Musculoskeletal News Roundup 19-July-07 BY LAUREN UZDIENSKI, JULY 19, 2007

M&A DJO announced on Monday plans for merger with ReAble (formerly Encore Medical). ReAble will acquire all outstanding shares of DJO stock, a transaction valued at approximately $1.6 billion and including the assumption of debt. The transaction will be funded... more

Cormet Gets FDA Approval, Stryker To Market As Early As 3Q:07 BY ARIELLA P. GOLOMB, MD, JULY 5, 2007

On Tuesday the FDA approved Corin's Cormet Hip Resurfacing System, introducing competition for Smith & Nephew's Birmingham Hip Resurfacing System in the U.S. Prior to Tuesday's announcement, the BHR was the only resurfacing system approved for the U.S. market. An... more

Amedica Files for $75 Million IPO BY JOHN MCCORMICK, MAY 23, 2007

Yestderday, Utah-based Amedica Corp. filed an initial public offering Securities and Exchange Commission to sell up to $74.75 million in common stock. The company's technology platform is in silicon nitride ceramics as applied to various types of orthopedic implants including... more

Orthopedic News Roundup 15-May-07 BY LAUREN UZDIENSKI, MAY 16, 2007

Earnings BioMimetic Therapeutics reported a 1Q:07 net loss of $5.7 million or $(0.34) per share, beating estimates of $(0.37) and comparing to a net loss of $3.8 million, or $(2.22) per share, in 1Q:06. The company reported revenues of $0.25... more

Vitamin E Poly Hits The Market BY DAVID KRESSEL, MAY 14, 2007

Biomet announced it gained FDA clearance to market the first vitamin E stabilized highly crosslinked polyethylene acetabular cup liner. Using the trade name E-Poly, Biomet's product uses the antioxidant vitamin E to reduce wear of the poly liner as oxidation... more

Fine-Tuning Computer-Assisted Orthopedic Surgery BY LAUREN UZDIENSKI, MAY 8, 2007

The National Institute of Standards and Technology announced an initiative last week to improve the precision and reliability of computer-assisted orthopedic surgery (CAOS) instruments in hip replacement surgery. NIST researchers have built a "phantom" hip that can be used by... more

Orthopedic News Roundup 26-Apr-07 BY LAUREN UZDIENSKI, APRIL 26, 2007

Earnings Large Joints Zimmer reported income of $233.4 million, or $0.98 per share, beating estimates of $0.93. The quarter compares to a profit of $205.6 million, or $0.82 per share in 1Q:06. Revenue rose 10% to $950.2 million from $860.4... more

Society for Biomaterials a Product Pipeline Crystal Ball BY DAVID KRESSEL, APRIL 24, 2007

Last week, we attended the Society for Biomaterials' annual conference. The event showcases the latest academic research and its broad applications across medical specialties. Roughly a third of the poster presentations focused on orthopedics, and most of the rest related... more

Market Trends From NYTimes Hip Resurfacing Article BY ARIELLA P. GOLOMB, MD, APRIL 17, 2007

Hailing hip replacement as one of the "great success stories of modern medicine," the New York Times published an article on Saturday emphasing the benefits of hip resurfacing as an interim step before traditional total hip replacement. There are a... more

Orthopedic News Roundup 1-Mar-07 BY LAUREN UZDIENSKI, MARCH 1, 2007

Earnings Biologics LifeCell reported 4Q:06 product revenues of $39.3 million, an increase of 45% over $27.0 million in 4Q:05, but missed analysts' estimates of $39.5 million. The growth was attributed to increased demand for the Company's AlloDerm® Regenerative Tissue Matrix.... more

Cormet Gets FDA Panel's Conditional Support BY ARIELLA P. GOLOMB, MD, FEBRUARY 23, 2007

Yesterday, the FDA Advisory Panel met and recommended Corin's Cormet hip resurfacing device for approval with conditions including a post marketing approval study, surgeon training and labeling. Prior to the meeting FDA raised questions about Corin's PMA submission relating to... more

Orthopedics News Roundup 15-Feb-07 BY LAUREN UZDIENSKI, FEBRUARY 15, 2007

Earnings Tutogen announced results for first fiscal quarter ending December 31, 2006. Total revenues increased 43% to $11.5 million, compared to $8.0 million in the comparable quarter of fiscal year 2006. U.S. revenues increased 50%, and international revenues increased 27%... more

Dane Miller to buy Biomet for $10.9 billion: 10 Months to Close BY JOHN MCCORMICK, DECEMBER 18, 2006

This morning Biomet's board of directors announced an agreement to be acquired by Dane A. Miller, the company's longtime CEO who was pushed aside in March of this year. Miller and his backers - a consortium of private equity firms... more

Yet Again, Synvisc Will Not Have To Share Reimbursement Code BY ARIELLA P. GOLOMB, MD, DECEMBER 15, 2006

In October we reported that Genzyme, maker of the viscosupplement Synvisc, announced a CMS decision grouping all industry viscosupplementation products into the same reimbursement code in January 2007. The coding change meant that reimbursement for viscosupplementation treatments will be based... more

Orthopedic News Roundup 2-Nov-06 BY HUYEN NGUYEN, NOVEMBER 3, 2006

Earnings Biologics: Orthovita reported 3Q:06 product sales came in at $11 million, up 32% compared to 3Q:05. Net loss for the quarter was $3.7 million, or a loss of $0.07 per share. The Company beat analysts' EPS estimates by $0.02,... more

Synvisc To Share Reimbursement Code BY ARIELLA P. GOLOMB, MD, OCTOBER 31, 2006

In a press release yesterday, Genzyme, maker of Synvisc, announced a CMS decision that would group all viscosupplementation products into the same reimbursement code in January 2007. The company stated that they would fight hard to dispute this decision (through... more

Orthopedic News Roundup 19-Oct-06 BY HUYEN NGUYEN, OCTOBER 19, 2006

Earnings Dental: Lifecore Biomedical announced that 1Q:07 net sales increased 12% to $15 million. Net income for the quarter was $1.1 million, representing a year-over-year increase of 9%. The Company was in-line with analysts' estimates and reported earnings of $0.08... more

Orthopedic News Roundup 21-Sept-06 BY HUYEN NGUYEN, SEPTEMBER 21, 2006

Earnings: Biomet reported its 1Q:07 earnings totaled $0.44 per share (excluding the adoption of the share-based payment) which was $0.01 more than what analysts were expecting. Revenues increased by 5% to $508 million (foreign currency had a $3 million favorable... more

Orthopedic News Roundup 17-Aug-06 BY HUYEN NGUYEN, AUGUST 17, 2006

Earnings: Biologics: Tutogen reported 3Q:06 sales of $10 million and a net loss of $1.1 million, or $0.07 per fully diluted share compared to the same quarter last year. The Company would have experienced breakeven results without ~$1.1 million in... more

Orthopedic News Roundup 3-Aug-06 BY HUYEN NGUYEN, AUGUST 3, 2006

Earnings: Biologics: IsoTis OrthoBiologics reported 2Q:06 revenue of $10.8 million, up 43% compared to $7.5 million in 2Q:05. Its U.S. division grew 22%, while international revenues grew 39%. The Company has three distribution channels: U.S. independent agents, international distributors and... more

Exactech's 2Q:06 - A Good Quarter BY HUYEN NGUYEN, AUGUST 2, 2006

On Tuesday, Exactech reported 2Q:06 revenues of $26.6 million, which represents an increase of 11% over 2Q:05. The Company reported $0.18 diluted earnings per share (EPS) and beat analysts' earnings estimates by $0.01. Net income for the quarter was a... more

Orthopedic News Roundup 27-Jul-06 BY HUYEN NGUYEN, JULY 27, 2006

Earnings Results: Biologics: Anika Therapeutics announced 2Q:06 net sales increased 11% to $7.1 million. Product revenues grew 74% while licensing, milestone and contract revenue was down 77%. The large product sales growth was partially driven by higher demand for OrthoVisc®;... more

Will Landis's Next Victory Be a Win For The Orthopedics Sector? BY ARIELLA P. GOLOMB, MD, JULY 26, 2006

Last Sunday, Floyd Landis won the Tour de France. Although this victory has been called into question today by doping allegations, his next big battle is going to be tackling the avascular necrosis in his right hip caused by a... more

Orthopedic News Roundup 12-Jul-06 BY HUYEN NGUYEN, JULY 12, 2006

Appointment: Biomet, Inc. appointed Charles E. Niemier as President of EBI's operations following the resignation of its former president, Bart J. Doedens, M.D. Mr. Niemier has been a member of the senior management team and Board of Directors for more... more

Orthopedic News Roundup 6-Jul-06 BY HUYEN NGUYEN, JULY 6, 2006

Appointments: Tutogen Medical appointed Dr. Karl Koschatzky to the position of Managing Director. Dr. Koschatzky will replace Manfred Kruger, who was Tutogen's President of International operations and Managing Director of the German subsidiary. IsoTis OrthoBiologics appointed James William (Jim) Poser,... more

Zimmer Gains FDA Approval For Ceramic Hip BY ARIELLA P. GOLOMB, MD, JULY 6, 2006

Zimmer announced today that it received FDA approval of its Premarket Approval Application (PMA) to market the Trilogy AB® Ceramic-on-Ceramic Acetabular System. Zimmer originally submitted its request for approval to market the Trilogy AB products in December 2004. The product... more

Orthopedic News Roundup 29-Jun-06 BY HUYEN NGUYEN, JUNE 29, 2006

Appointment: Spine Wave announced that it has elected Ron Pickard to its Board of Directors. In addition to his role on the Board, Mr. Pickard will be actively involved in key projects including the development and commercialization of Spine Wave's... more

Biomet Also Receives Subpoena BY JOHN MCCORMICK, JUNE 26, 2006

This morning, Biomet announced that it has a subpoena from the Department of Justice, Antitrust Division, requesting documents regarding possible violations of federal criminal law, including possible violations of the antitrust laws, relating to the manufacture and sale of orthopedic... more

Zimmer Gets Dept. of Justice Subpoena BY JOHN MCCORMICK, JUNE 26, 2006

Zimmer Holdings Inc. said Friday the Justice Department's antitrust division subpoenaed company documents pertaining to an investigation of possible violations of federal criminal law, including possible violations of antitrust laws, involving the manufacture and sale the Company's standad lines of... more

Breakthrough For Rare Orthopedic Genetic Disorder; Broad Implications For Orthopedics BY ARIELLA P. GOLOMB, MD, JUNE 9, 2006

A Single Codon Mutation Causes A Debilitating Disease Fibrodysplasia Ossificans Progressiva (FOP) is a rare autosomal dominant genetic disorder that causes muscles and other connective tissue to turn into bone and is estimated to affect one in two million patients... more

Has the Total Hip Market Slowed? What are the Drivers Looking Ahead? BY JOHN CHOPACK, JUNE 1, 2006

There has been a significant amount of discussion by Wall Street analysts regarding a slowdown in the total hip arthroplasty market. While we agree that there has been a slowdown, we believe it is more moderate than the rest of... more

Orthopedic News Roundup 4-May-06 BY HUYEN NGUYEN, MAY 4, 2006

Appointment: Scient'x USA appointed Tracy Brown as Vice President of Sales. Mr. Brown was formerly with Microtek Medical and Stryker Spine, both in the area of marketing and sales. Scient'x, SA is a HealthpointCapital portfolio company. Clinical Update: At the... more

1Q:06 Preliminary Earnings Summary BY HUYEN NGUYEN, APRIL 27, 2006

The first group of orthopedic companies reported their 1Q:06 this week and took in $5.3 billion so far. The total aggregated revenues for the quarter were up by 7% from $4.9 billion in 1Q:05. The industry netted $637.8 million, a... more

Orthopedic News Roundup 20-Apr-06 BY HUYEN NGUYEN, APRIL 20, 2006

Many orthopedic companies will be reporting their 1Q:06 results in the next few weeks. The table below provides a listing of conference call dial-in numbers and webcasts for the investment community. How the overall orthopedic industry fared in the first... more

A Surgeon's Look at Costs In Total Joint Arthroplasty BY LAING RIKKERS, MARCH 31, 2006

One of the most informative sessions at AAOS was a section of the Health Policy Update Symposium delivered by William L. Healy, M.D. of the Lahey Clinic. Healy gave real-life examples of the complicated and delicate balance of hospital economics,... more

Dane Miller to Retire BY JOHN MCCORMICK, MARCH 27, 2006

This morning, legendary orthopedic CEO, Dane A. Miller, Ph.D., Biomet's President and Chief Executive Officer and co-founder, announced his decision to retire. He will remain a Director and serve as a consultant. The Biomet Board has appointed Senior Vice President... more

2006 Orthopedic Industry Forecast - Strong Growth to Continue BY EDITOR, MARCH 21, 2006

Our current forecast for the orthopedic industry projects continued long term growth of 15%. For 2006, we expect growth to be slightly below this trend, at 12%. Despite continued strength in other segments of the industry, hip and knee reconstruction... more

Scientific Advisory Board AAOS Sessions BY JOHN CHOPACK, MARCH 16, 2006

In addition to the Top Sessions we chose, we have added AAOS presentations by our Scientific Advisory Board members. Please click on the link at the bottom to view the entire list. Wednesday, March 22 10:30 AM - 12:30 PM127Changing... more

Ceramics Getting Stronger? BY JOHN MCCORMICK, MARCH 15, 2006

Developments in ceramics has always been of great interest to participants in our industry. We thought we would alert you to this article in Wired Magazine that summarized some recent findings in ceramic technology. In essence, scientists are finding that... more

Our Top Picks -- AAOS 2006 Educational Sessions BY JOHN CHOPACK, MARCH 14, 2006

With the AAOS in Chicago fast approaching, we have put together a list of "Hot Sessions" to check out. Please click on the link at the bottom to view the entire list. Adult Reconstruction, Hip and KneeSunday, March 26, 2006... more

Analyst Meetings during AAOS BY KAREN FEDER, FEBRUARY 23, 2006

Looking ahead to the AAOS 73rd Annual Meeting on March 22-26, 2006 taking place at the McCormick Place Convention Center in Chicago, we wanted to post the latest information on Company Analyst meetings that will be held in Chicago: -... more

Orthopedic News Roundup 23-Feb-06 BY LAING RIKKERS, FEBRUARY 23, 2006

Financing: BioMimetic Therapeutics, Inc. filed a registration statement for an Initial Public Offering. Earnings: Medtronic 3Q Earnings climb 23 percent. CryoLife fourth quarter 2005 revenues increased 13% over fourth quarter 2004 Gross margins for full year 2005 increased to 53%... more

Wright Medical's Forecast Disappoints BY DAVID KRESSEL, FEBRUARY 10, 2006

Last night Wright (WMGI) reported slightly better than expected results, but lowered 2006 guidance dramatically. Revenue guidance dropped modestly, but EPS guidance was knocked down substantially because Wright will increase investments in R&D and sales and marketing. 2006 Guidance, and... more

Smith & Nephew Reports 15% Growth in Orthopedics BY DAVID KRESSEL, FEBRUARY 10, 2006

Smith & Nephew reported results for 4Q05 and FY2005, and they were strong particularly within their Orthopedics segment. For the quarter, they saw 15% growth (ex F/X) in orthopedic sales to $1,267 million, which broke down as follows: *Knees: +12%... more

New Medical Device Treats Osteoporosis BY DAVID KRESSEL, JANUARY 12, 2006

A New Jersey company, Juvent, is introducing a new way to treat osteoporosis. The product was initially developed at the State University of NY at Stony Brook, with funding from the US Army and NASA. The Juvent 1000 Dynamic Motion... more

Biomet Gets FDA Approval BY SHELLY ACHAIBAR, JANUARY 6, 2006

Biomet received FDA approval for the C2a-Taper Acetabular System, a ceramic-on-ceramic hip replacement system. Biomet's FDA approval follows Stryker, Wright Medical, Encore Medical, Smith & Nephew and Zimmer. President and CEO Dane A. Miller, Ph.D. stated, "We are pleased to... more

Orthopedic News Roundup 15-Dec-05 BY HUYEN NGUYEN, DECEMBER 15, 2005

Since we have one more week until the arrival of the holiday season, many companies are wrapping up their businesses as they patiently await for fiscal year 2005 to end. So far, December has been a good month for orthopedic... more

Insiders Buying Stryker's Shares (EDITORIAL) BY JOHN MCCORMICK, NOVEMBER 3, 2005

It has never been empirically proven that insider (e.g. management and director) buying of a company's stock guarantees that the stock poised to rise, but it has also never been proven to be a bad sign. That's stating the obvious.... more

Orthopedic News Roundup 27-Oct-05 BY HUYEN NGUYEN, OCTOBER 27, 2005

It has been a busy week for many CEOs and CFOs in the orthopedic device sector. In the past two weeks orthopedic companies reported 3Q:05 sales of $4.7 billion which was a 12% increase over the 3Q:04. Net earnings for... more

Implant Pricing: Not Black and White (EDITORIAL) BY JOHN MCCORMICK, OCTOBER 21, 2005

Is Wall Street's shrill reaction to hip and knee implant pricing concerns overblown? Even with sophisticated econometric tools such a question is difficult to evaluate because we are dealing with an expectations driven phenomenon. So we have our doubts about... more

Novel Products to Rejuvenate Hip Market Growth BY JOHN CHOPACK, SEPTEMBER 21, 2005

The rate of growth in the hip market has been somewhat lackluster since the 2Q:04. That quarter marked the first two FDA approvals for ceramic-on-ceramic hips for Stryker and Wright Medical. For the 12 months prior to the 2Q:04, Stryker... more

Orthopedic News Roundup 9-Sept-05 BY HUYEN NGUYEN, SEPTEMBER 9, 2005

The FDA Orthopedic and Rehabilitation Devices Panel held a meeting September 8th and 9th to rule on two important issues: Smith & Nephew's hip resurfacing device and the design of clinical studies for spinal devices. You can find background information... more

Orthopedic News Roundup 12-Aug-2005 BY HUYEN NGUYEN, AUGUST 12, 2005

This week we completed the orthopedic reporting calendar as a few more companies reported earnings, starting with Synthes, the number #1 trauma company worldwide. Synthes reported 20% growth in both top and bottom line for 1H:05. Consolidated sales reported at... more

Orthopedic News Roundup 5-Aug-05 BY HUYEN NGUYEN, AUGUST 5, 2005

This week we finish off the first half of 2005 reporting season with 17 orthopedic companies* released their financial numbers. In 2Q:05, in an aggregated total, orthopedic revenues increased 16% ($3.8 billion vs. $3.2 billion) and a 25% increased in... more

Orthopedic News Roundup 29-Jul-05 BY HUYEN NGUYEN, JULY 29, 2005

Earnings: Please refer to the table (below) for individual company sales and earnings. It's all about earnings this week... Biologics: Clearly, the big winner this week is LifeCell Corp. who reported strong earnings on Monday stock was up 24% at... more

Biomet Revises 4Q:05 Earnings Guidance Downward BY JOHN CHOPACK, JUNE 21, 2005

Biomet announced last evening that it was reducing its 4Q:05 earnings guidance as a consequence of hitting the low end of its previous range for 4Q:05 revenues. The Company stated that revenues totaled $503 million for the 4Q:05 which is... more

Hip Resurfacing in the U.S.? BY JOHN CHOPACK, JUNE 8, 2005

About six months ago I had an individual come into my office asking about an article he had recently read in a local newspaper regarding hip resurfacing. The man was approximately 40 years old and was too young for a... more

1Q:05 Large Joint Review: Knees Remain Strong while Hips Weaken BY JOHN CHOPACK, MAY 9, 2005

With most of the major large joint market share leaders reporting their 1Q:05 financials, we examine the strength of the market. At first glance revenue growth of hip products seems to be slowing while knee growth accelerates. Hips We estimate... more

Zimmer (ZMH:NYSE) Crushes the Street - Again. BY JOHN CHOPACK, MAY 2, 2005

During the 4Q:04 Zimmer beat analyst expectations by $0.07 in earnings-per-share and $18 million in revenues. For their encore, Zimmer reported 1Q:05 adjusted earnings-per-share (diluted) of $0.75 and revenues of $829 million which was exceeded analysts' forecasts by $0.08 and... more

Wright Medical (WMGI:NASDAQ) Reports 1Q:05 BY JOHN CHOPACK, MAY 2, 2005

Wright reported 1Q:05 revenues of $82.6 million which was a 10% increase over the 1Q:04. Excluding the effect of currency, WMGI revenues increased 9%. The 10% growth in revenues was almost 3% slower than the revenue growth reported during the... more

Stryker Corp. (SYK:NYSE) Reports 1Q:05 Financials; Beats the Street by $0.02 BY JOHN CHOPACK, APRIL 25, 2005

SYK reported 1Q:05 revenues of $1.2 billion which was a 16% increase over the 1Q:04 and beat analyst expectations by $2 million. The Company reported earnings of $0.42 per diluted share which was $0.02 better than analyst were forecasting. The... more

Elderly Population: New Census Bureau Forecast BY JOHN MCCORMICK, APRIL 25, 2005

Last Thursday the US Census Bureau released new state-by-state projections on the aging of the U.S. population which showed not only how it expects the nation to age, but how the population is expected to shift geographically over the next... more

Gain-Sharing: The Lawyers View BY JOHN CHOPACK, APRIL 18, 2005

Background on Gain Sharing. The Hospital Corporation of America ("HCA") has recently asked the Office of Inspector General ("OIG") of the Department of Health & Human Services ("HHS") to allow for "gain-sharing" arrangements. These gain-sharing arrangements would allow hospitals to... more

Corin Group PLC (CRG.LN) Reports a 20% Increase Net Profit in FY2004 BY HUYEN NGUYEN, APRIL 18, 2005

On April 5th, Corin reported fiscal year 2004 financial results. Total sales grew by 9% on a constant currency basis and 7% as reported. Group turnover for the year was reported at £25.6 million, compared to £24 million in 2003.... more

The Industry Subpoenaed: Our Perspective BY JOHN MCCORMICK, APRIL 4, 2005

The healthcare industry has long been the subject of regulation by complex laws that do not exist in other industries and which, under certain circumstances, may seem almost excessive and counter-intuitive. The enforcement of these laws has been significant and... more

Preservation of Motion in the Lumbar Spine: A Trip Report BY JOHN MCCORMICK, MARCH 21, 2005

At the end of last week, we attended the University of South Florida's "Preservation of Motion in the Lumbar Spine" course to check in on how leading surgeons are coming along with motion preserving spinal procedures and related surgical implant... more

What Price Innovation? | EDITORIAL | BY JOHN MCCORMICK, MARCH 21, 2005

I was struck by economist Paul Krugman's article "America's Senior Moment" in the most recent New York Review of Books. In the article Krugman assails the Bush Administration's push for social security "privatization" with the fervor of a campus radical,... more

4Q:04 Orthopedic Wrap-up BY JOHN CHOPACK, MARCH 14, 2005

We have aggregated the 4Q:04 and 3Q:04 reported revenues (includes the effects of foreign currency) for 16 public orthopedic companies. Although we would have liked to use revenue growth rates which excluded foreign currency, a majority of the companies report... more

Exactech (EXAC:NASDAQ) Reports 4Q:04 Financials which were slightly below Analyst Expectations BY JOHN CHOPACK, MARCH 7, 2005

EXAC reported revenues of $21.3 million during the 4Q:04 which was a 14% increase over the 4Q:03 but was $300 thousand below analyst's expectations. Earnings-per-share on a diluted basis totaled $0.17 which was also slightly below analyst expectations of $0.16.... more

Encore Medical (ENMC:NASDAQ) Reports 4Q:04 and 2004 Year-end Results BY JOHN CHOPACK, MARCH 7, 2005

From a business development and strategy execution standpoint/2004 was an excellent year for Encore. Management completed two acquisitions (Empi and Osteoimplant Technologies, Inc.) which fits the overall business development strategy of ENMC: growth via acquisition. The acquisitions helped drive revenues... more

2005 AAOS: Louder, Yet Quieter than Ever Before BY JOHN CHOPACK, MARCH 1, 2005

The 2005 American Academy of Orthopaedic Surgeon Annual Conference was unique to recent meetings. It was louder in terms of the amount of marketing, size of exhibits and mass advertising, yet it was quieter in terms of business development and,... more

2005 AAOS Analyst Meeting Reviews BY JOHN CHOPACK, MARCH 1, 2005

This year we attended Smith & Nephew's, Biomet's, Stryker's, and Encore Medical's analyst meetings. All were very professional and well attended. Here are our notes from each: Smith & Nephew Overview: Although Smith & Nephew posted the best large joint... more

FIVE HOT AAOS Sessions Plus 20 others worth a close look BY EDITOR, FEBRUARY 22, 2005

Overwhelmed with all the education opportunities? Join the club. Good news for you, though - the HealthpointCapital research team has whittled down the program to 26 of the most controversial and best-hosted side sessions. Minimally Invasive Breaks Out Every year... more

2005 American Academy of Orthopaedic Surgeons (AAOS) Preview BY JOHN CHOPACK, FEBRUARY 14, 2005

It's here again, the annual AAOS conference. Thousands are ready to descend on Washington, D.C. the week of February 21st to learn of new surgical techniques, new products and to develop business and relationships. While it is hard to predict... more

Wright Medical (WMGI:NASDAQ) Reports 4Q:04 Financials BY JOHN CHOPACK, FEBRUARY 14, 2005

Wright reported both 4Q:04 and year-end 2004 financials on Thursday evening. 4Q:04 revenues totaled $77.7 million a 13% increase over 4Q:03 revenues and at the upper end of management's previous guidance of revenues of $76-$78 million. Revenues for the year... more

Smith & Nephew (SNN:NYSE) Reports 4Q:04 & 2004 Financials BY JOHN CHOPACK, FEBRUARY 7, 2005

After a strong report from Zimmer earlier in the week, Smith & Nephew followed suit on Thursday. SNN reported revenues totaled £332 million for the 4Q:04 which was a 14% increase over the 4Q:03 on a constant currency basis. Earnings-per-share... more

Zimmer (ZMH:NYSE) Beats the Street by $0.07 in EPS and $18 Million in Revenues; Stock Gains 11% on Tuesday. BY JOHN CHOPACK, FEBRUARY 7, 2005

After Stryker and DePuy reported somewhat modest financial reports two weeks ago, it seemed like many industry analysts and experts were talking of a potential slowdown in orthopedic growth. Then Zimmer reported revenues of $800 million for the 4Q:04 which... more

Stryker Corp. (NYSE:SYK) Reports 4Q:04 and 2004 Financials BY JOHN CHOPACK, JANUARY 31, 2005

Stryker reported 4Q:04 revenues of $1.156 billion which was an increase of 15% on a reported basis over the 3Q:04. This was slightly below analyst expectations of $1.158 billion in revenues. Earnings for the 4Q:04 totaled $0.40 per diluted share... more

Johnson & Johnson (NYSE:JNJ) Reports 4Q:04 Results: We Examine DePuy's Charite BY JOHN CHOPACK, JANUARY 31, 2005

JNJ reported revenues of $12.8 billion for the 4Q:04 which was a 13% increase over the 4Q:03. DePuy, JNJ's orthopedic division, reported revenues of $952 million for the 4Q:04. This was a 19% increase as reported and a 15% increase... more

Direct-to-Consumer Advertising Takes Hold in Orthopedics | EDITORIAL | BY JOHN CHOPACK, JANUARY 24, 2005

Direct-to-consumer advertising has become the most powerful means of marketing pharmaceuticals over the last decade. For years we have seen these strange advertisements which typically only mention the name of a drug and the manufacturer, but withhold any information regarding... more

Smith & Nephew (SNN:NYSE) Receives FDA Approval For Ceramic-Ceramic Hip and Introduces Imageless Computer-Assisted Surgical Navigation System. BY JOHN CHOPACK, JANUARY 10, 2005

SNN became the fourth orthopedic manufacturer to gain FDA approval of a ceramic-on-ceramic hip behind Stryker Corp., Wright Medical and Encore Medical. Ceramic-on-ceramic hips offer superior wear characteristics compared to traditional polyethylene and metal-on-metal hips providing the potential to last... more

Biomet (BMET:NASDAQ) Reports 2Q:05 Adjusted Earnings of $0.38 which is In-line with Analyst's Expectations. BY JOHN CHOPACK, DECEMBER 20, 2004

BMET reported adjusted earnings-per-share of $0.38 during the 2Q:05 which was a 19% increase over the 2Q:04. The adjusted earnings do not include certain non-recurring costs associated with the acquisition of Merck KGaA's interest in Biomet Merck and the acquisition... more

Wright Medical Holds Annual Analyst Guidance Call - The Future is Bright BY JOHN CHOPACK, DECEMBER 13, 2004

Wright Medical (WMGI:NASDAQ) held its annual analyst guidance call to provide management's outlook for sales, earnings and product trends for the 4Q:04, year-end 2004/2005 and 2006. The forecasts, we think, look strong: 4Q:04 - The Company has reaffirmed its October... more

VIOXX Wars Good News for Large Joint Reconstruction Market BY ROBIN R. YOUNG CFA, NOVEMBER 29, 2004

The lawyer's ads are all over the country and all over the two broadest media outlets we know - television and the internet. "Learn about Vioxx, the Vioxx recall and potential health risks!" "Are you a Vioxx Patient? Find out... more

Smith & Nephew (SNN:NYSE) Reports Strong 3Q:04 Financials BY JOHN CHOPACK, NOVEMBER 8, 2004

Smith & Nephew reported revenues of '288.9 million for the 3Q:04 which was a 12% increase over the 3Q:03 on a constant currency basis. Earnings for the 3Q:04 totaled '4.99p per share which was a 15% increase over the 3Q:03.... more

Encore Medical (ENMC:NASDAQ) Reports 12% Sales Growth in 3Q:04 BY JOHN CHOPACK, NOVEMBER 8, 2004

Encore reported its 3Q:04 financials on Monday of last week. Revenues totaled $30.6 million which was a 12% increase over 3Q:03. Earnings totaled $0.04 (excluding certain non-recurring expenses) which was a $0.01 higher than analysts were anticipating and a significant... more

Exactech (EXAC:NASDAQ) Reports 15% Revenue Increase for 3Q:04 / Misses Analyst Consensus Estimates BY JOHN CHOPACK, NOVEMBER 3, 2004

Exactech reported net revenues of $19.5 million for the 3Q:04 which was a 15% increase over the 3Q:03, but slightly below analyst expectations of $20 million. Earnings totaled $0.14 per diluted share which was a 20% increase from the 3Q:03... more

Zimmer Holdings (ZMH:NYSE) Reports $700 million in 3Q:04 Sales, up 13% (10% constant currency) BY JOHN CHOPACK, NOVEMBER 3, 2004

Zimmer also beat earnings expectations by $0.03 per share. Hip revenues rose 14%, knees revenues were up 16% but spine declined 2%. These percentages were as reported. We give the constant currency numbers later in this note. Guidance for the... more

Wright Medical (WMGI:NASDAQ) Reports 28% biologics growth and 23% Hip growth in 3Q:04 BY JOHN CHOPACK, NOVEMBER 3, 2004

Wright Medical reported a blistering 28% rate of growth for its biologics products as well as a solid 23% rate of revenue growth for its hip products. Clearly, this is a company that is gaining market share from biomaterials. Hip... more

The 3Q:04 Earnings Season is Half-way Completed for Large Joint Manufacturers: Any Trends? BY JOHN CHOPACK, OCTOBER 25, 2004

Three of the seven leading large joint orthopedic manufacturers have reported their 3Q:04 financials. So far, market growth rates on a constant currency basis remain in-line with the growth rates reported by industry leaders DePuy, Biomet and Stryker in the... more

Ceramic-on-Ceramic Hip Arthroplasty: Impact on the Market BY JOHN CHOPACK, OCTOBER 25, 2004

Given that the first ceramic-on-ceramic hip arthroplasty approval came approximately a year and half ago, we thought it would be a good time to analyze its effect on the market to date and what we expect in the future. Although... more

VIOXX: Systemic Problems Doom Another Systemic Drug BY ROBIN R. YOUNG CFA, OCTOBER 4, 2004

Since its introduction, more than 91 million prescriptions for VIOXX have been written in the United States for patients with arthritis pain in either the hip or knee. If one were to include all the prescription Cox-2 inhibitor drugs like... more

Wright Medical (WMGI: NASDAQ) Lowers 3Q:04 Earnings Guidance by $0.04 BY JOHN CHOPACK, SEPTEMBER 27, 2004

WMGI announced that it was lowering its previous earnings per share guidance of $0.13-$0.15 to a range of $0.09-$0.11, or approximately $3.2 - $3.9 million. However, the Company maintained its current revenue projections for the 3Q:04 of $68 - $70... more

Biomet (BMET: NASDAQ) Beats Analyst's 1Q:05 Earnings Expectation by $0.01 Per Share BY JOHN CHOPACK, SEPTEMBER 20, 2004

BMET reported adjusted earnings of $0.36 which excluded the acquisition of Biomet Merck joint venture and Interpore International. This was an increase of 20% over the 1Q:04 and $0.01 better than consensus estimates. However, BMET's revenues of $438 million, which... more

Hip Net Revenue Growth Rate Slows During 2Q:04, But Knees Accelerate BY JOHN CHOPACK, SEPTEMBER 20, 2004

After the dust cleared from the 2Q:04 earnings season and we had time to analyze the large joint reconstruction market, it was clear that a cursory glance at the market showed a declining revenue growth rate in the hip market... more

Smith & Nephew (SNN:NYSE) Reports 14% Rise in Orthopedic Revenues 21% Increase in U.S. Knee Sales BY JOHN CHOPACK, AUGUST 16, 2004

Smith & Nephew reported an 8% increase in revenues which totaled '350 million for the 2Q:04. Orthopedics was the strongest segment of SNN, increasing by 14% worldwide and 18% in the US. Growth in Endoscopy sales rebounded from flat to... more

Encore Medical (ENMC:NASDAQ) Reports Revenues Totaled $29.3 Million for the 2Q:04; Analyst were Expecting $30.4 Million BY JOHN CHOPACK, AUGUST 16, 2004

The slight miss in net revenues combined with missing analyst EPS expectations by $0.01 ($0.04 reported versus a $0.05 estimate) sent shares of ENMC downward by 23% on Monday. Encore follows Stryker, Exactech, Wright, and Zimmer who have all seen... more

Zimmer Beats the Street by $0.03 in EPS and $4 Million in Revenues; Stock Sells Off 13% in Intraday Trading BY JOHN CHOPACK, AUGUST 16, 2004

It is like a broken record; another solid orthopedic earnings report and investors dump shares, again. In similar fashion to Stryker, Exactech and Wright Medical, Zimmer (NYSE: ZMH) beat analysts earnings expectations and investors reacted by selling shares. The difference... more

Zimmer Holdings (ZMH:NYSE) Reports 2Q:04 Earnings - Beats the Street and Sells Off BY JOHN CHOPACK, AUGUST 2, 2004

It seems that orthopedic investors have it in their mind this earnings season that unless a company crushes its numbers and guides significantly to the upside, they will dump shares. This happened to Stryker, Exactech and Wright Medical and now... more

Wright Medical Reports a 22% Increase in Revenues and a 34% Increase in Earnings; Stock is Off as Much as 16% on Wednesday BY JOHN CHOPACK, AUGUST 2, 2004

In a common trend this earnings season, Wright Medical reported in our opinion one of the best second quarters of 2004 in the orthopedic sector and investors congratulated the Company by dumping shares. Wright Medical is one of four large... more

Exactech (EXAC:NASDAQ) Reports Solid 2Q:04 - 15% Increase in Revenues & Earnings BY JOHN CHOPACK, JULY 26, 2004

EXAC reported revenues of $20.4 million which was a 15% increase over revenues of $17.8 million during the 2Q:04. The Company also reported net income of $1.6 million or $0.16 per diluted share, which represented a 15% increase over the... more

We Pause to Examine the Large Joint Market Ahead of the Conclusion of Earnings Season BY JOHN CHOPACK, JULY 19, 2004

With DePuy, Stryker and Biomet reporting during the last three weeks, this is a good time to identify specific topics imperative to the remainder of the sector's earnings releases over the next several weeks. Large Joint Companies Earnings 2Q:04 Reports... more

Hospitals Push Back on Future Price Increases BY ROBIN R. YOUNG CFA, JULY 19, 2004

In 1995 the average coated femoral stem cost $2,458. Today, coated femoral stems range from $4,225 to $5,097 each for an 85% price increase in 9 years. As we demonstrate in the following table, the rate of component price increases... more

Stryker Corp. (SYK:NYSE) 2Q:04 Earnings Increase by 42%which Beats the Street by $0.03 BY JOHN CHOPACK, JULY 19, 2004

SYK reported earnings totaled $152.7 million or $0.37 per diluted share during the 2Q:04. This 42% increase over the 2Q:03 beat analyst expectations by $0.03. It also triggered several analyst downgrades including First Albany, Wells Fargo and Bank of America.... more

Biomet (BMET:NASDAQ) Beats the Street by $0.01 in EPSand $16 Million in Revenues BY JOHN CHOPACK, JULY 12, 2004

Biomet announced that revenues totaled $447 million for the 4Q:04 and $1.6 billion in 2004 representing a 19% and 16% increase, respectively. Adjusted earnings (for the acquisitions of Merck Joint Venture and Interpore Cross) per share totaled $0.37 for the... more

Current Concepts in Joint Replacement (CCJR) BY JOHN CHOPACK, JUNE 7, 2004

Current Concepts in Joint Replacement (CCJR) is the best conference for hip, knee and shoulder reconstruction. The meeting allows for surgeons to present new data, debate topics and demonstrate new techniques via live surgery. Our major take-away is that surgeons... more

It's About Time! Mobile-Bearing Knee Is Headed for a Down Classification BY JOHN CHOPACK, JUNE 7, 2004

On Wednesday of last week, (June 2/2004) an FDA panel recommended to down classify both the tricompartmenal and unicompartmental mobile bearing knee by a vote of 6 to 2 and 5 to 3, respectively. Although this doesn't guarantee that the... more

CMS Proposes New Reimbursement Rates - DRG 209 Rate Increases by 2% BY JOHN CHOPACK, MAY 24, 2004

Center for Medicare and Medicaid Services (CMS) released its 2005 proposed payments for inpatient procedures on May 18th/2004. CMS is calling for a 2% increase in DRG 209 payments bringing the total payment to $10,034 up from $9,839 the year... more

A Review of the Five Largest Orthopedic Companies' 1Q:04 Financial Results BY JOHN CHOPACK, MAY 17, 2004

We tabulated the five largest general orthopedic companies' financial results for the 1Q:04. The companies include Stryker, Zimmer, Biomet, Smith & Nephew and Wright Medical, each of which has a market capitalization in excess of $1 billion. Although many subscribers... more

Keramos Ceramic-on-Ceramic Sales Drive an 18% Increase in 1Q:04 Revenues at Encore Medical BY JOHN CHOPACK, MAY 10, 2004

Encore Medical was third to market with an FDA approved ceramic-on-ceramic total hip system behind Wright Medical and Stryker. Being one of the first to market has provided significant benefits at Encore. Keramos hip sales already represent approximately 20% of... more

Smith & Nephew Reports Strong 1Q:04 Financials Driven by Further Penetration of Oxinium Sales BY JOHN CHOPACK, MAY 10, 2004

Sir Christopher O'Donnell, CEO of Smith & Nephew, held an analyst call to discuss the Company's progress throughout the first 90 days of 2004. The Company reported revenues of '302 million which was a 12% increase in underlying sales growth... more

Kyocera Corporation and Kobe Steel Collaborate to Form #1 Japanese Orthopedics Company BY ROBIN R. YOUNG CFA, MAY 3, 2004

Ranking, respectively #1 and #2 among Japanese orthopedics companies - but lagging behind American and UK firms (who hold, we estimate, the top 5 positions in the Japanese market) - the medical products businesses of Kyocera and Kobe Steel have... more

Zimmer's Management Takes 2 Hours out of their Schedule to Discuss Both Its Operational Results and Status of the Orthopedic Market BY JOHN CHOPACK, MAY 3, 2004

Zimmer reported its 1Q:04 financial results on Monday evening and on Tuesday morning held a 2 hour and 15 minute conference call with industry analysts to discuss its results. Although some analysts may believe that 2 hours is too long... more

Exactech Reports a 16% Increase in 1Q:04 Revenues BY JOHN CHOPACK, MAY 3, 2004

Exactech (EXAC:NASDAQ) announced that revenues totaled $21 million during the 1Q:04 which was a 16% increase over the 1Q:03. Knee sales, which accounted for approximately 60% of 1Q:04, increased by 21% over the same period a year. The Optetrak knee... more

Wright Medical's Hip Sales Increase 52% In Quarter. Ceramic-On-Ceramic and Metal Bearings The Key. BY JOHN CHOPACK, MAY 3, 2004

Wright Medical (WMGI:NASDAQ) reported that revenues totaled $74.9 million during the 1Q:04 which was a 28% increase (22% on a constant currency basis) over the 1Q:03. WMGI also reported that $6.6 million of these revenues flowed through the P&L to... more

Stryker Corp & DePuy Report 1Q:04 Earnings and Provide Insight into Strength of Large Joint Reconstructive Market BY JOHN CHOPACK, APRIL 19, 2004

DePuy and Stryker Corp. both reported their 1Q:04 earnings during the last week of trading activities. This provided some insight into both the strength of the Large Joint Orthopedic market and how the additional orthopedic companies will report during the... more

A Random Walk Down the Academy's Halls BY JOHN CHOPACK, MARCH 22, 2004

Stryker Corp. (SYK:NYSE), in similar fashion to last year, brought and introduced a majority of its operational leaders of its various operating divisions. However, a significant portion of the analyst meeting, especially Q&A, centered around Stephen MacMillan, President & COO,... more

The 2004 AAOS Whirlwind BY JOHN CHOPACK, MARCH 22, 2004

The 2004 American Academy of Orthopedic Surgeons hit with the speed and intensity of a tornado. It wasn't a destructive tornado but rather a whirlwind of innovative technology and merger activity. Biomet (BMET:NASDAQ) couldn't wait for the official Academy to... more

Encore Medical Turns It Around in 2003 BY JOHN CHOPACK, MARCH 8, 2004

Encore (ENMC) management reported revenues of $27.9 million and $108.1 million during the 4Q:03 and 2003, respectively. This represented a 6% and a 13% increase over 4Q:02 and 2002 revenues. In our opinion, the most important revenue turn around during... more

The Machine Keeps Rolling - Zimmer Beats the Street, Again BY JOHN CHOPACK, FEBRUARY 23, 2004

The 4Q:03 conference call offered the first glimpse into how Zimmer's (NYSE:ZMH) integration of Centerpulse was progressing. Ray Elliott, CEO of the “New Zimmer”, offered some insights. Zimmer currently has “100 fulltime employees managing 250 major integration projects and 1,700... more

Exactech Reports 2003 Financials – Revenues Increase by 20% Driving a 22% Increase in Net Income BY JOHN CHOPACK, FEBRUARY 23, 2004

Exactech reported that 2003 revenues totaled $71.3 million, an increase of 20% over 2002. Knee sales, which now total 57.4% of sales, increased by 23% to $41.3 million during the 4Q:02. Hips had a disappointing 2003, as they increased by... more

Wright Medical – Best Company in Orthopedics? BY JOHN CHOPACK, FEBRUARY 23, 2004

For the just completed quarter and year, Wright Medical (NASDAQ:WMGI) reported, we believe, the best quarter and year in orthopedics. First, Wright's seven year investment in the Investigational Device Exemption (IDE) ceramic-on-ceramic clinical hip trial delivered huge dividends in 2003.... more

Smith & Nephew Reports Orthopedic Revenues Total $867 Million , Up 16% from 2003 BY JOHN CHOPACK, FEBRUARY 9, 2004

Smith & Nephew (SNN) reported that revenues totaled $1.9 billion during 2003 which was an 11% increase in underlying sales over 2002. Underlying orthopedic revenues increased by 16% during 2003, totaling $867 million. The Orthopedic growth of 16% was 7%... more

Stryker Corp Reports 21% Sales Rise in 4th quarter BY JOHN CHOPACK, FEBRUARY 2, 2004

Stryker (SYK) reported that revenues totaled $1.1 billion in 4Q:03 and $3.63 billion for the full year 2003. This represented a 21% and a 20% increase over the respective periods last year. The increase in revenues helped drive a 27%... more

It's Almost Routine – Zimmer Crushes Analysts' Consensus Estimates... Again BY JOHN CHOPACK, JANUARY 26, 2004

Zimmer reported an abridged 4Q:03 financial report last week along with updated guidance for 2004. While many investors have come to expect Zimmer to exceed analyst expectations, we thought the 4Q:03 could represent the most difficult challenge for the Company... more

Smith & Nephew posts 16% ortho revenue growth (+23% in knees!) BY EDITOR, DECEMBER 22, 2003

Smith & Nephew (SNN:NYSE) held a trading update conference call on Thursday to provide an update on its performance during the 2H:03 – which at 16% orthopedic growth is in-line with the respective market. However, SNN's knee growth rate of... more

Biomet Reports 14% Sales Increase BY EDITOR, DECEMBER 22, 2003

Biomet (BMET:NASDAQ) reported its 2Q:04 financials on Thursday. As a consequence of not reporting financials based on a calendar fiscal year, BMET is the earliest to report their quarter. Therefore, both analysts and orthopedic investors pay close attention to BMET... more

Wright Medical - Growing for the Long Run BY EDITOR, DECEMBER 15, 2003

Guidance to 2005? This is a famously conservative management, so to guide out to 2005 is cause to sit up and take notice. What's going on at Wright medical? Strong biologics and ceramic on ceramic hip components certainly. But, we... more

Encore Medical Receives FDA approval for Ceramic on Ceramic Hip Components BY EDITOR, DECEMBER 1, 2003

Let the new offering of stock begin! Encore now joins Stryker and Wright Medical with a ceramic-on-ceramic acetabular component. For both of the prior companies, this longer lasting hip replacement has been a significant driver of both revenues and cash... more

Conference Focus on Materials BY EDITOR, NOVEMBER 24, 2003

At the 78th annual reunion of the Société Française de Chirurgie Orthopédique et Traumatologique (SO.F.C.O.T.) held last week in Paris, the focus was clearly on new materials - ceramics, plastics and biologics. And among the most successful new materials companies... more

The Krispy Kanary in the Orthopedic Mine is singing BY EDITOR, NOVEMBER 24, 2003

Like much of orthopedics, Krispy Kreme sells a lifestyle product. And the basic emotion encompassed in that product is comfort. For eighty five cents, Krispy Kreme delivers a nearly perfect, melt in your month donut and, with that, a happy,... more

Merrill Lynch downgrades Smith and Nephew BY EDITOR, NOVEMBER 24, 2003

About a year ago, Merrill downgraded the entire orthopedics industry saying that revenue growth rates were about to moderate from 2002's blistering 14% growth rates. Medicare was the proximate reason. Unfortunately (for Merrill) orthopedic revenues accelerated in 2003 to 18%... more

Smith and Nephew merge with Stryker? BY EDITOR, NOVEMBER 5, 2003

Earlier today, Reuters published a short story recounting an occasional rumor that Smith & Nephew (SNN) and Stryker (SYK) are in merger discussions. It is a rumor and may very well prove false, but the logic is strong. Here's our... more

Encore Prints More Money BY EDITOR, NOVEMBER 3, 2003

There are two ways to print money if you are a private citizen; counterfeit it – and we all know where that leads – or print stock certificates. Encore announced that it intends to print another 7 million shares. That... more

Of Zoomers, Boomers and Macaroomers BY EDITOR, SEPTEMBER 29, 2003

The data we see coming from the Centers for Medicare and Medicaid (CMS) tells us that the large joint reconstruction market is being driven by people born before 1944. Not Boomers. Not Zoomers – whatever they are – or any... more

In a testament to second chances, InFUSE gets CMS approval for $8,900. BY EDITOR, AUGUST 4, 2003

Rejected one year ago... Medtronic came back with new data and CMS, while rejecting InFuse again using one analytical approach found another way to show that InFUSE does indeed meet the threshold requirement for receiving a new technology add-on payment.... more

Stryker adds $107 million in new orthopedic implant sales for the quarter. BY EDITOR, JULY 21, 2003

That's a 26% year-over-year rate of revenue growth. On a constant currency basis, the growth rate was 19%. To put this in context, for all of 2003, Stryker's orthopedic revenue growth was 18%, on a constant currency basis 17%. For... more

It's going to be a great Quarter, Year and Decade BY EDITOR, JULY 14, 2003

Despite being asked by the Merrill analyst to comment on the prospects for the Next Gen product (manufactured by Zimmer... oops, she meant Next Generation), Biomet's CEO, Dane Miller, was his usual wry self as he announced that overall sales... more

Smith and Nephew's Oxinium technology driving 70% year-over-year sales jump BY EDITOR, JUNE 23, 2003

Smith and Nephew's large joint recon business is a muscular enterprise. In its preview of the first half, SNN's management reported that orthopedic revenues are expected to rise 15% year-over-year (YOY), with knees leading the way at a 22% growth... more

Merrill turns bearish on Orthopedics while Stephens puts its money into a sparkling Gem of a spine center. Guess who we think is the smarter investor! BY EDITOR, APRIL 7, 2003

Merrill Lynch's ratings downgrade of, in effect, the entire Orthopedics industry will rank, we think, with Business Week's infamous "Death of Equities" cover story - which coincided with the beginning of the greatest bull market in history - as one... more

Complete Archive